Advances in Nuclear Oncology:: Diagnosis and Therapy

 Oncology  Comments Off on Advances in Nuclear Oncology:: Diagnosis and Therapy
Jun 012020
 

The diagnostic and therapeutic achievements in radiopharmaceuticals and nuclear medicine instrumentation – PET, SPECT, MR, CT and their hypbrids PET-CT and SPECT-CT – are the result of the interdisciplinary research efforts of cell-biologists, chemists, pharmacologists, physicists, computer-scientists, engineers, nuclear medicine physicians, and oncologists. The clinical implications of these achievements have made nuclear medicine indispensable in the management of cancer. This superbly illustrated text on modern nuclear medicine applications in the diagnosis and treatment of cancer describes the state of the art and the current position of nuclear medicine in the light of these recent developments. It is intended as a valuable update also for non-nuclear medicine specialists working in oncology. Nuclear medicine as part of molecular imaging and therapy has changed radically in the last decade. The growing importance and clinical impact of these changes in the near future has impelled the internationally renowned editors and contributors to put them on record in Advances in Nuclear Oncology.
GET IT FREE HERE
ALTERNATIVE LINK
Share Button

Cancer Immunology: A Translational Medicine Context

 Immunology, Oncology  Comments Off on Cancer Immunology: A Translational Medicine Context
May 302020
 

Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume is focused on immunopathology of cancers. The interactions between cancerous cells and various components of the innate and adaptive immune system are fully described. The principal focus, however, is very much on clinical aspects, the aim being to educate clinicians in the clinical implications of the most recent research and new developments in the field. Over the past decade, understanding of the interactions between the immune system and cancerous cells has increased markedly, leading to the development of combinatorial immunotherapeutic strategies to combat cancer. This translational, clinically oriented book will be of special value to clinical immunologists, hematologists and oncologists.

GET IT FREE HERE

https://nitroflare.com/view/9AF56C963A8C08D/Cancer_Immunology_A_Translational_Medicine_Context.pdf

ALTERNATIVE LINK

https://filejoker.net/9x3x7bjxs5zd

Share Button

Malignant: How Bad Policy and Bad Evidence Harm People with Cancer

 Oncology  Comments Off on Malignant: How Bad Policy and Bad Evidence Harm People with Cancer
May 292020
 

How hype, money, and bias can mislead the public into thinking that many worthless or unproven treatments are effective.

Each week, people read about new and exciting cancer drugs. Some of these drugs are truly transformative, offering major improvements in how long patients live or how they feel―but what is often missing from the popular narrative is that, far too often, these new drugs have marginal or minimal benefits. Some are even harmful. In Malignant, hematologist-oncologist Dr. Vinayak K. Prasad writes about the many sobering examples of how patients are too often failed by cancer policy and by how oncology is practiced. Throughout this work, Prasad illuminates deceptive practices which

• promote novel cancer therapies long before credible data are available to support such treatment; and
• exaggerate the potential benefits of new therapies, many of which cost thousands and in some cases hundreds of thousands of dollars.

Prasad then critiques the financial conflicts of interest that pervade the oncology field, the pharmaceutical industry, and the US Food and Drug administration.

This is a book about how the actions of human beings―our policies, our standards of evidence, and our drug regulation―incentivize the pursuit of marginal or unproven therapies at lofty and unsustainable prices. Prasad takes us through how cancer trials are conducted, how drugs come to market, and how pricing decisions are made, asking how we can ensure that more cancer drugs deliver both greater benefit and a lower price. Ultimately, Prasad says,

• more cancer clinical trials should measure outcomes that actually matter to people with cancer;
• patients on those trials should look more like actual global citizens;
• we need drug regulators to raise, not perpetually lower, the bar for approval; and
• we need unbiased patient advocates and experts.

This well-written, opinionated, and engaging book explains what we can do differently to make serious and sustained progress against cancer―and how we can avoid repeating the policy and practice mistakes of the past.

GET IT FREE HERE

https://nitroflare.com/view/081019363FA1BD8/1421437635.pdf

ALTERNATIVE LINK

https://filejoker.net/7ep7ltahf2q5

Share Button

Medullary Thyroid Cancer

 Oncology  Comments Off on Medullary Thyroid Cancer
May 252020
 

This text provides a comprehensive, contemporary review of this disease and serves as an important resource for clinicians and researchers with an interest in medullary thyroid cancer. The book reviews the initial management of the patient with thyroid nodules, including risk factors, appropriate genetic evaluation of suspected/known medullary thyroid cancer, and appropriate screening for diseases associated with inherited forms of medullary thyroid cancer, including primary hyperparathyroidism and pheochromocytomas. It includes an in-depth discussion of the optimal surgical management of patients with sporadic and inherited disease, those with locoregional metastases, distant metastases, and recurrent medullary thyroid cancer. The long-term follow-up and management of patients with medullary thyroid cancer is highlighted.

Medullary Thyroid Cancer will serve as a useful resource for all providers and researchers interested in this relatively rare and challenging malignancy. It highlights recent guidelines for the management of patients with medullary thyroid cancer and discusses controversies within the literature. All chapters are written by experts in the field and incorporate multiple disciplines, including Surgery (Endocrine Surgery, General Surgery, and Otolaryngology), Endocrinology, Radiology, Medical Oncology and Genetic Counseling.

GET IT FREE HERE

https://nitroflare.com/view/9E5BE79F36C9845/Medullary_Thyroid_Cancer.pdf

ALTERNATIVE LINK

https://filejoker.net/tewdtmlphjfu

Share Button

Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and Progression, Second Edition

 Oncology  Comments Off on Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and Progression, Second Edition
May 212020
 

The purpose of this book is to provide a contemporary overview of the causes and consequences of prostate cancer from a cellular and genetic perspective. Written by experts in the fields of epidemiology, toxicology, cell biology, genetics, genomics, cell-cell interactions, cell signaling, hormone signaling, and transcriptional regulation, the text covers aspects of prostate cancer from disease initiation to metastasis.
Chapters explore in depth the cells of origin for prostate cancer, its genomic subtypes, neural transcription factors in disease progression, epigenetic regulation of chromatin, and many other topics. This book distinguishes itself from other texts on prostate cancer by its focus on cellular and genetic mechanisms, as opposed to clinical diagnosis and management. As a result, this book will be of broad interest to basic and translational scientists with familiarity of these topics, as well as to trainees at earlier stages of their research careers.

GET IT FREE HERE

https://nitroflare.com/view/306DB211BC14FCC/3030326551.epub

https://nitroflare.com/view/52620222193C1E5/3030326551.pdf

ALTERNATIVE LINK

https://filejoker.net/dz3okb98xral

https://filejoker.net/8nrwpcy8tjll

 

Share Button

Gunderson and Tepper’s Clinical Radiation Oncology – 5th Edition (March 2020 Release)

 Oncology  Comments Off on Gunderson and Tepper’s Clinical Radiation Oncology – 5th Edition (March 2020 Release)
May 192020
 

A comprehensive, multidisciplinary resource for the entire radiation oncology team, Gunderson & Tepper’s Clinical Radiation Oncology, 5th Edition, thoroughly covers all aspects of this complex and dynamic field. Concise, templated chapters cover the basic biology of oncologic disease processes as well as updated treatment algorithms, the latest clinical guidelines, and state-of-the-art techniques and modalities. More than 1,000 images―detailed anatomy drawings, radiographic images, and more―provide outstanding visual support for every area of the text.

  • Divides content into three distinct sections for quick access to information: Scientific Foundations, Techniques and Modalities, and Disease Sites. Disease Site chapters include overviews summarizing the most important issues and concluding discussions on controversies and problems.
  • Features new and expanded content on molecular and cellular biology and its relevance in individualized treatment approaches, stereotactic radiation therapy, radiosurgery, proton therapy, biologic therapy, precision radiation therapy, targeted radiation, dosing guidelines for better quality of life and improved patient outcomes, and more.
  • Includes new chapters on Radiation Physics: Particle Therapy, Interventional Radiology, Radiation Therapy in the Elderly, Palliative Care, Quality and Safety, and Immunotherapy with Radiotherapy.
  • Provides guidance on single-modality and combined-modality approaches, as well as outcome data including disease control, survival, and treatment tolerance.
  • Includes access to videos on Intraoperative Irradiation, Prostate Brachytherapy, Penile Brachytherapy, and Ocular Melanoma.

GET IT FREE HERE

http://nitroflare.com/view/41320039830A8EC/0323672469.pdf

ALTERNATIVE LINK

https://filejoker.net/scxju179iimz

Share Button

Circulating Tumor Cells in Breast Cancer Metastatic Disease (Advances in Experimental Medicine and Biology

 Oncology  Comments Off on Circulating Tumor Cells in Breast Cancer Metastatic Disease (Advances in Experimental Medicine and Biology
May 152020
 

This book is aimed to summarise the key aspects of the role of circulating tumour cells (CTCs) in breast cancer, with special attention to their contribution to tumour progression and establishment of metastatic disease. We aim to give a clear overview of the knowledge about CTCs, framed in the context of breast cancer, by analysing basic and clinical research carried out so far. In a broader sense, we will address what are the main clinical needs of this disease based on its molecular heterogeneity (subtypes) and lay out the knowledge and understanding that CTCs are giving about it and how they are contributing and can still improve the better monitoring and management of breast cancer patients. We will discuss the evidences of the use of CTCs as a tool to monitor cancer progression and therapy response, based on the prognostic and predictive value they have, as well as a tool to unravel mechanisms of resistance to therapy and to identify new biomarkers allowing to predict therapy success. Moreover, we will analyse the main aspects of ongoing clinical trials and how they can contribute to determine the clinical utility of CTCs as a breast cancer biomarker. We will also touch upon general knowledge or basic notions of the biology of the metastatic process in epithelial cancers, in order to understand the origin and biology of CTCs. In this sense, we will pay special attention to EMT (epithelial to mesenchymal transition), dormancy and minimal residual disease, three key aspects that determine the outcome of the disease. We will also cover general aspects on the isolation and characterization techniques applies to the study of CTCs, and also the possibilities that the study of CTCs, as a biomarker with biological function, is opening in terms of understanding the biology of metastatic cells and the identification of therapeutic targets based on the functional and molecular characterization of CTCs. Lastly, we will try to foresee the future of CTCs in terms of clinical application and implementation in the clinical routine.

GET IT FREE HERE

https://nitroflare.com/view/82F76FCCBD813AF/3030358046.epub

https://nitroflare.com/view/B746FCCDF507B39/3030358046.pdf

ALTERNATIVE LINK

https://filejoker.net/hwdf8d3hgpb3

https://filejoker.net/g0p91zi6dboc

Share Button

Tumor Cell Metabolism: Pathways, Regulation and Biology

 Oncology  Comments Off on Tumor Cell Metabolism: Pathways, Regulation and Biology
May 142020
 

The four sections of this book cover cell and molecular biology of tumor metabolism, metabolites, tumor microenvironment, diagnostics and epigenetics. Written by international experts, it provides a thorough insight into and understanding of tumor cell metabolism and its role in tumor biology. The book is intended for scientists in cancer cell and molecular biology, scientists in drug and diagnostic development, as well as for clinicians and oncologists.

GET IT FREE HERE

https://nitroflare.com/view/6148CB711233488/Tumor_Cell_Metabolism_Pathways%2C_Regulation_and_Biology.pdf

ALTERNATIVE LINK

https://filejoker.net/uy1mntjvcfia

Share Button

Genetics for Oncologists: The Molecular Genetic Basis of Oncologic Disorders (Remedica Genetics)

 Genetics, Oncology  Comments Off on Genetics for Oncologists: The Molecular Genetic Basis of Oncologic Disorders (Remedica Genetics)
May 112020
 

During the past decade enormous progress has been made in our understanding of the molecular genetic basis of many oncological disorders, and such information is already beginning to impact on clinical practice. This book provides oncologists with a concise summary of what is presently known about the genetic basis of monogenic and polygenic oncologic disorders. The glossary provides a thorough grounding in the fundamentals of genetic terminology and techniques. With its quick reference format, “Genetics for Oncologists” is designed for use by busy practitioners.
GET IT FREE HERE
ALTERNATIVE LINK
Share Button

Radiotherapy in Prostate Cancer: Innovative Techniques and Current Controversies

 Oncology, Radiology  Comments Off on Radiotherapy in Prostate Cancer: Innovative Techniques and Current Controversies
May 082020
 

Today, the arsenal of “high-precision” or “targeted” radiotherapy includes a variety of techniques and approaches that, like the pieces of a puzzle, need to be put together to provide the prostate cancer patient with high-level optimized radiation treatment. This book examines in detail the role of these innovative radiation techniques in the management of prostate cancer. In addition, a variety of current controversies regarding treatment are carefully explored, including whether prophylactic treatment of the pelvic lymphatics is essential, the magnitude of the effect of dose escalation, whether a benefit accrues from hypofractionation, and what evidence exists for the superiority of protons or heavy ions. Radiotherapy in Prostate Cancer: Innovative Techniques and Current Controversies is intended for both radiation oncologists and urologists with an interest in the up-to-date capabilities of modern radiation oncology for the treatment of prostate cancer.

GET IT FREE HERE

https://nitroflare.com/view/760329E3CD4DFF1/Radiotherapy_in_Prostate_Cancer_Innovative_Techniques_and_C.pdf

ALTERNATIVE LINK

https://filejoker.net/nc2coqkjak4f

Share Button